Latest News
Binance To Convert Stablecoins To Own Binance USD
Key points: Binance To Convert USD Coin, Pax Dollar And TrueUSD Into Binance USD Move Seen As A Power Grab Who Wins, Who Loses? On Monday, the world

Here’s Why NIO Stock Plunged 6.66% Despite Upbeat Q2 Results
Key points: NIO stock plunged 6.66% despite releasing upbeat Q2 financial results. The EV manufacturer issued lower guidance for Q3 triggering the

Is Tortilla’s Share Price One to Watch?
Key points: Tortilla shares are down almost 25% in 2022 However, there are positive signs for the fast-casual restaurant chain Consumer demand trends look favourable

Regis Corp, RGS, Up 18% – Meme Stock Status Or Real Turnaround?
Key points: Regis Corporation is up 18% premarket This follows a recent doubling in RGS stock Is this the beginning of some meme stock status, or tracking a real business

Premier African Minerals (PREM) Shares Rose on Assay Results
Key points: Premier African Minerals (PREM) shares edged higher on assay results. However, investors largely ignored the results given the pending

InMed Pharma Down 84% YonY, Up 2,420% Today, Really Down 4% Maybe?
Key points: InMed Pharma stock is up 2,422% this morning Or we could say INM is down 4%, even 84% Are we interested in real or nominal prices, over what time period?

Union Jack Oil (UJO) Shares Surged 7.27% on Maiden H1 Profit
Key points: Union Jack Oil (UJO) shares surged 7.27% on maiden H1 profit. The oil and gas company had £10.5 million in cash at the end of H1.

Halfords Up 12% On Trading With Inflation News – Good News
Key points: Halfords shares are up 12% this morning on a trading update Even when we correct for inflation HFD is managing to keep pace The key is that most of the sales

Synairgen (SNG) Share Price Rallied 13% on Upbeat Phase 2 Data
Key points: Synairgen shares rallied 13.4% on phase 2 trial data from COPD patients. The company is testing the effectiveness of SNG001 against vir

UBS Backs Boohoo At Revolution Beauty – What Next?
Key points: UBS has just bought 6% of Revolution Beauty Group REVB is still suspended - so, is this one leg of a trade? Or is UBS backing the Boohoo idea that Revolution

CVS Health (CVS) Stock Edged Higher on Signfiy Health Purchase
Key points: CVS Health stock edged higher on the $8 billion Signify Health purchase. The health company is expanding into the primary healthcare ma

Boohoo (BOO) Shares Have Fallen 30.2% in a Month. What Next?
Key points: Boohoo shares have fallen 30.23% in the past month. What’s next? The fast fashion company faces challenges that fueled the decline.

Creatd Waves Bye Bye To NASDAQ: Stock Falls 45% In Two Days
Key points: Created is about to lose its NASDAQ quote CRTD stock is down 45% in two days on the back of this The likely solution is a capital raise, but how dilutive wil

Why UK Oil & Gas (UKOG) Shares Rallied 27.5% Despite No News
Key points: Despite no news, the UK Oil & Gas (UKOG) share price rallied 27.5%. Today’s rally adds to yesterday’s rally as buyers push prices h

DWAC Down 22% – Can Trump’s Social SPAC Win The Vote?
Key points: DWAC is down 22% premarket, DWACW 29% This seems to be over concern about Trump's social SPAC There's a vote today on whether to continue the experiment

Orosur Mining (OMI) Shares Soared 49% on Pepas Drilling Update
Key points: Orosur Mining shares soared 49.7% on the Colombian operations update. The firm discovered high-grade gold deposits at the Pepas prospec

Ethernity Networks, Down 83% From Peak, Up 16% Today – Is This The Turn?
Key points: Ethernity Networks lists on OTCQB today The aim is likely to gain a rerating of the shares Americans do, often enough, seem to value tech stock higher than L

Cardano Price Forecast: ADAUSD Still Basing Pattern, Bull Threat
Key points: Cardano Continues To Form A Base From May ADAUSD Has Again Produced Short & Intermediate-Term Bull Signals Cardano Bulli Price Forecasts

Inland Homes Down 25% – Housebuilder Losing Money In Roaring Market
Key points: INL shares are down 25% this morning on a trading update Banking covenants are being tested, there's a strategic review to come Significant losses mean the In

Avacta Up 4% On Orphan Drug Designation – Is This Important?
Key points: Orphan drug status for AVA6000 is a vital part of the development process This has now been granted, which is good But why is there only a 4% reaction in the
